Replies to post #203895 on Amarin Corp Plc (AMRN)

[amarinbullfromchicago]

If market thought we were 50% chance of approval, we’d be trading much lower. I think we currently should be higher, but that doesn’t really count for much when I can buy or sell a million shares between 18 and 19. It seems our moves are always a bit exaggerated when news comes out, either up or down.

Even though we’d probably drop to $8-10 on denial, I still think we could be worth $25+ in 2 years since insurance and sales would slowly raise our value to a fraction (still high) of where we’d be without approval.

[Jamaalish]

But maybe you're right. What I just said didn't seem to matter a whole lot after the ICER report. A bad grade would have been terrible for the company, but the good report didn't raise prices very much. The price movements for Amarin often don't make sense to me, and I end up just really confused and having no idea what is happening!

[marzan]

Jamaalish, Just watch the dynamics in revenue or weekly scripts how it rockets once FDA approves with a wider label that none of us might have thought of. It is going to be for all adults to prevent CVD, imo. All the insurance companies will provide coverage. Watch how those gL scripts fade away switching to V in no time. gL scripts we see now are due to coverage denied for V, no doubt about it. The day JT received the New Information has changed all his plan of operation to overdelivery, I mean supply of V here. He is working on it full swing.